CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 4 Planned sale PRESIDENT AND CEO sold 5,000 shares at $16.49 ($82,453)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale CHIEF OPERATING OFFICER sold 6,667 shares at an average $18.39 ($122,579)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 7,500 shares at an average $20.05 ($150,391)
- 4 Planned sale PRESIDENT AND CEO sold 7,500 shares at an average $20.06 ($150,415)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,250 shares at an average $18.69 ($60,738)
- 144 Insider Sale of Securities
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 5,000 shares at an average $16.07 ($80,366)
- 4 Planned sale PRESIDENT AND CEO sold 5,000 shares at $16.42 ($82,096)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 11 of 40 · 798 filings